-
-
-
-
-
E337161-1mgERK Inhibitor II, Negative Control is a cell-permeable pyrazolopyridazinol that serves as a (-) control for ERK Inhibitor II. ERK Inhibitor II, Negative Control has been shown to exhibit little activity towards ERK1 and ERK2 or in blocking
-
E337963-5mgERK Inhibitor III is a cell-permeable compound that acts as a substrate-, but not ATP-, site-targeting inhibitor of ERK. ERK Inhibitor III selectively inhibits the EGF-stimulated cellular phosphorylation of ERK substrates Rsk-1 and Elk-1, but not
-
E610181-25mgERK inhibitor III.
-
E610181-5mgERK inhibitor III.
-
-
-
E413691-100mgInformationErvogastat (PF-06865571) is a potent diacylglycerol acyltransferase 2 inhibitor (DGAT2i) that reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).
-
E413691-10mgInformationErvogastat (PF-06865571) is a potent diacylglycerol acyltransferase 2 inhibitor (DGAT2i) that reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).